14.07.2017 10:00:01

DGAP-News: UMS United Medical Systems International AG

DGAP-News: UMS AG Reports on Financial Statements at April 30, 2017

DGAP-News: UMS United Medical Systems International AG / Key word(s): Final Results/Final Results
UMS AG Reports on Financial Statements at April 30, 2017

14.07.2017 / 10:00
The issuer is solely responsible for the content of this announcement.


UMS AG Reports on Financial Statements at April 30, 2017

Hamburg, July 14, 2017. UMS United Medical Systems International AG i.L. (UMS, ISIN DE 0005493654 / WKN 549365) has reported on the financial statements for the fiscal year from May 1, 2016 to April 30, 2017. The results of ordinary business activities amounted to EUR 5k, following minus EUR 113k in the previous year. Earnings per share were EUR 0.00, following minus EUR 0.03 in fiscal year 2016. Liquidity amounted to EUR 1.8 million at the balance sheet date, or EUR 0.41 per year, following EUR 15.4 million or EUR 3.60 per share in the previous year. The decrease is primarily attributable to the distributions made in the past fiscal year totaling EUR 12.4 million or EUR 2.90 per share. Equity now amounts to EUR 2.4 million or EUR 0.56 per share (previous year: EUR 14.8 million or EUR 3.46 per share).

The proceedings against the Company's previous tax advisors, Ebner Stolz Wirtschaftsprüfer Steuerberater Rechtsanwlte, are particularly significant for the timing of the liquidation going forward. Now that the Hamburg Court of Appeals has found for the Company in the suit against Ebner Stolz on appeal and Ebner Stolz has been ordered to pay damages and the entire costs of the proceedings, Ebner Stolz has now filed a petition challenging the denial of leave to appeal the decision of the Court of Appeals, which did not allow it to appeal the decision to the German Supreme Court. Accordingly the timing of the rest of these proceedings remains uncertain.

We expect to receive an answer to our challenge of the preliminary rulings in our special VAT audit in the coming weeks.

The UMS AG financial statements for the fiscal year from May 1, 2016 to April 30, 2017 can be downloaded from the Company's website at www.umsag.com.

About UMS International AG i.L.

UMS International AG i.L. is a corporation listed in the Prime Standard segment of Deutsche Börse AG. The Company sold its interest in United Medical Systems (DE), Inc. and thus essentially all its assets on August 14, 2014. The shareholders agreed to this sale at the special meeting held on September 25, 2014. The agreement was consummated on November 11, 2014. Now that the assets have been sold, the purpose of the Company is to manage its own assets. In addition, the shareholders resolved to dissolve the company as of April 30, 2015.

Contact

Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail:
investor@umsag.com



14.07.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: UMS United Medical Systems International AG
Borsteler Chaussee 53
22453 Hamburg
Germany
Phone: +49 (0)40 - 500 177 - 00
Fax: +49 (0)40 - 500 177 - 77
E-mail: investor@umsag.com
Internet: www.umsag.com
ISIN: DE0005493654
WKN: 549365
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange

 
End of News DGAP News Service

592505  14.07.2017 

fncls.ssp?fn=show_t_gif&application_id=592505&application_name=news&site_id=smarthouse

Nachrichten zu UMS United Medical Systems International AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu UMS United Medical Systems International AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!